BNR — Burning Rock Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $156.15m
- $86.02m
- CNY539.57m
Annual cashflow statement for Burning Rock Biotech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -797 | -971 | -654 | -347 | -55.3 |
| Depreciation | |||||
| Non-Cash Items | 333 | 401 | 317 | 239 | 64.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -62.4 | -11.2 | -52.2 | -36.5 | -59.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -478 | -457 | -256 | -92.3 | -28.4 |
| Capital Expenditures | -213 | -75.5 | -9.38 | -5.98 | -5.25 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 295 | 68 | 0.084 | 1.56 | 0.858 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 81.7 | -7.46 | -9.3 | -4.41 | -4.39 |
| Financing Cash Flow Items | -3.82 | -12 | -41.9 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -52.9 | -86.2 | -48.8 | -0.072 | 1.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -486 | -514 | -310 | -93.1 | -41.1 |